Adage Capital Partners’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-650,000
| Closed | -$437K | – | 975 |
|
|
2023
Q2 | $437K | Hold |
650,000
| – | – | ﹤0.01% | 785 |
|
|
2023
Q1 | $904K | Hold |
650,000
| – | – | ﹤0.01% | 801 |
|
|
2022
Q4 | $819K | Hold |
650,000
| – | – | ﹤0.01% | 848 |
|
|
2022
Q3 | $2.8M | Sell |
650,000
-64,781
| -9% | -$279K | 0.01% | 832 |
|
|
2022
Q2 | $3.73M | Sell |
714,781
-35,219
| -5% | -$184K | 0.01% | 833 |
|
|
2022
Q1 | $8.99M | Hold |
750,000
| – | – | 0.02% | 726 |
|
|
2021
Q4 | $14.7M | Hold |
750,000
| – | – | 0.03% | 588 |
|
|
2021
Q3 | $19.5M | Hold |
750,000
| – | – | 0.04% | 463 |
|
|
2021
Q2 | $16.5M | Buy |
750,000
+17,500
| +2% | +$385K | 0.03% | 543 |
|
|
2021
Q1 | $17.1M | Buy |
732,500
+82,500
| +13% | +$1.93M | 0.04% | 514 |
|
|
2020
Q4 | $11.2M | Buy |
+650,000
| New | +$11.2M | 0.02% | 562 |
|